These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4968077)

  • 21. [Characteristics of the reaction of the macrophage lysosomal apparatus in guinea pigs immunized with a live and a killed Br. abortus culture].
    Shuvalov LP; Korn MIa; Gavril'chak AV
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Jun; (6):26-9. PubMed ID: 821275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Theoretical, practical and statistical basis for a general control method of activity for anti-Brucella vaccines.
    Bosseray N; Plommet AM; Plommet M
    Dev Biol Stand; 1984; 56():257-70. PubMed ID: 6489617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA vaccine encoding L7/L12-P39 of Brucella abortus induces protective immunity in BALB/c mice.
    Luo DY; Li P; Xing L; Zhao GY; Shi W; Zhang SL; Wang XL
    Chin Med J (Engl); 2006 Feb; 119(4):331-4. PubMed ID: 16537031
    [No Abstract]   [Full Text] [Related]  

  • 24. [CHARACTERISTICS OF IMMUNITY IN SKIN VACCINATION AND REVACCINATION WITH VACCINE FROM BR. ABORTUS 104-M STRAIN. III. STATE OF IMMUNITY IN REPEATED VACCINATIONS WITH VACCINE FROM BR. ABORTUS 104-M STRAIN IN EXPERIMENTS ON GUINEA PIGS].
    TARAN IF; NELIAPIN NM; POLIAKOVA AM
    Zh Mikrobiol Epidemiol Immunobiol; 1964 Jan; 41():77-81. PubMed ID: 14184312
    [No Abstract]   [Full Text] [Related]  

  • 25. [ATTEMPT AT VACCINATION OF GUINEA PIGS AGAINST BRUCELLA MELITENSIS BY MEANS OF A KILLED VACCINE].
    QUATREFAGES H; CARRERE L; PETITDIDIER M
    Ann Inst Pasteur (Paris); 1965 Aug; 109():305-9. PubMed ID: 14336050
    [No Abstract]   [Full Text] [Related]  

  • 26. Liposomised recombinant ribosomal L7/L12 protein protects BALB/c mice against Brucella abortus 544 infection.
    Mallick AI; Singha H; Chaudhuri P; Nadeem A; Khan SA; Dar KA; Owais M
    Vaccine; 2007 May; 25(18):3692-704. PubMed ID: 17296251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A study of immunological cross-reaction between Yersinia enterocolitica 0:9 and Brucella abortus.
    Jian H; Chu TP
    Dev Biol Stand; 1984; 56():179-83. PubMed ID: 6436093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Brucella abortus (strain 544) variants.
    Hopkins IG; Thornton DH; Hebert CN
    J Biol Stand; 1981 Oct; 9(4):421-9. PubMed ID: 6798039
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparative efficacy of six Brucella vaccines in guinea-pigs.
    Cameron CM
    Onderstepoort J Vet Res; 1979 Dec; 46(4):229-30. PubMed ID: 551372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice.
    Vemulapalli R; Contreras A; Sanakkayala N; Sriranganathan N; Boyle SM; Schurig GG
    Vet Microbiol; 2004 Sep; 102(3-4):237-45. PubMed ID: 15327798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Morphologic reactions in brucella infections in guinea pigs prevaccinated with cellular components of virulent brucellea].
    Safronova VM; Baeva AA; Taran IF
    Zh Mikrobiol Epidemiol Immunobiol; 1976; (3):73-6. PubMed ID: 822661
    [No Abstract]   [Full Text] [Related]  

  • 32. [The behavior of P32- and S35-labeled Brucella endotoxins in the organism of normal and immunized guinea pigs].
    Jezyna C; Szaposznikow E
    Arch Hyg Bakteriol; 1968 Dec; 152(5):427-37. PubMed ID: 5741514
    [No Abstract]   [Full Text] [Related]  

  • 33. Evaluation of Brucella abortus DNA and RNA vaccines expressing Cu-Zn superoxide dismutase (SOD) gene in cattle.
    Sáez D; Guzmán I; Andrews E; Cabrera A; Oñate A
    Vet Microbiol; 2008 Jun; 129(3-4):396-403. PubMed ID: 18164561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protection of Brucella abortus RB51 revaccinated cows.
    Blasco JM; Moriyon I
    Comp Immunol Microbiol Infect Dis; 2005; 28(5-6):371-3; author reply 375-7. PubMed ID: 16182367
    [No Abstract]   [Full Text] [Related]  

  • 35. Immune responses and efficacy after administration of a commercial Brucella abortus strain RB51 vaccine to cattle.
    Olsen SC
    Vet Ther; 2000; 1(3):183-91. PubMed ID: 19757581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of Brucella abortus on growth of ovarian granulosa cell carcinoma].
    Litvinkova NP; Trubcheninova LP; Baryshnikov AIu
    Biull Eksp Biol Med; 1980 Nov; 90(11):600-2. PubMed ID: 6778536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antagonism between two immunogens extracted from Brucella (cell wall peptidoglycan and lipopolysaccharide fractions) and inactivity of the brucellin allergen in immunization of the mouse.
    Bosseray N; Plommet M
    Ann Microbiol (Paris); 1980; 131A(2):157-69. PubMed ID: 7387055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cross immunization of guinea-pigs with products of Brucellae abortus, melitensis and suis.
    KEPPIE J; WITT K; SMITH H
    Br J Exp Pathol; 1963 Feb; 44(1):84-7. PubMed ID: 14032018
    [No Abstract]   [Full Text] [Related]  

  • 39. Biochemical and biological properties of soluble protein preparations from Brucella abortus.
    Tabatabai LB; Deyoe BL
    Dev Biol Stand; 1984; 56():199-211. PubMed ID: 6436094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A combined DNA vaccine enhances protective immunity against Mycobacterium tuberculosis and Brucella abortus in the presence of an IL-12 expression vector.
    Yu DH; Li M; Hu XD; Cai H
    Vaccine; 2007 Sep; 25(37-38):6744-54. PubMed ID: 17681650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.